These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2969172)

  • 1. Open trial of mesoglycan in the treatment of cerebrovascular ischemic disease.
    Mansi D; Sinisi L; De Michele G; Di Geronimo G; Palma V; Brescia Morra V; Coppola N; Buscaino GA
    Acta Neurol (Napoli); 1988 Apr; 10(2):108-12. PubMed ID: 2969172
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesoglycan in treatment of patients with cerebral ischemia: effects on hemorheologic and hematochemical parameters.
    Vecchio F; Zanchin G; Maggioni F; Santambrogio C; De Zanche L
    Acta Neurol (Napoli); 1993 Dec; 15(6):449-56. PubMed ID: 8160557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesoglycan in acute focal cerebral ischemia].
    Cazzato G; Zorzon M; Masé G; Antonutti L; Iona LG
    Riv Neurol; 1989; 59(3):121-6. PubMed ID: 2531910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].
    Raso AM; Maggio D; Trogolo M; Rispoli P; Sandrone N; Pezzuto D; Bellan A; Melloni CD
    Minerva Cardioangiol; 1997; 45(7-8):383-92. PubMed ID: 9463174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mesoglycan and phlebopathy. A clinico-experimental contribution].
    Allegra C; Bonifacio M; Riccioni C; Tonelli V
    Minerva Med; 1986 Oct; 77(40):1887-92. PubMed ID: 2946005
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic action of oral mesoglycan in the pharmacologic treatment of the varicose syndrome and its complications].
    Petruzzellis V; Velon A
    Minerva Med; 1985 Mar; 76(12):543-8. PubMed ID: 3157887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trials of mesoglycan in pelvic inflammatory disease].
    Signorelli C; Tampucci S; Signorelli I
    Minerva Med; 1986 Oct; 77(41):1949-52. PubMed ID: 2946993
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan.
    Viliani T; Scarselli M; Pieri A; Gatti M; Santini M; Pasquetti P
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):21-9. PubMed ID: 19270639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of mesoglycan in the prevention of cerebral ischemia].
    Bettini R; Maino C; Gorini M
    Clin Ter; 2003; 154(1):13-6. PubMed ID: 12854278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical-instrumental evaluation of the effects of mesoglycan sulphate in chronic vascular encephalopathy.
    Orlandi G; Viapiano F; Massetani R; Ferrari M; Murri L
    Acta Neurol (Napoli); 1991 Jun; 13(3):255-60. PubMed ID: 1833956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of the efficacy of mesoglycan in the treatment of venous diseases of the legs].
    Vercelloni M; Cogo R; Furcolo F; Monzani G; Casali W; Di Franco G
    Clin Ter; 1985 Nov; 115(3):173-6. PubMed ID: 2935355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
    Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
    Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW; Ropper AH; Zervas NT
    Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mesoglycan and fibrinolysis: therapeutic activity of oral mesoglycan in venous thrombosis. A short-term clinical, biological and instrumental study].
    Vittoria A; Cappelli R; Messa GL; Auteri A
    Minerva Med; 1986 Oct; 77(40):1867-72. PubMed ID: 2946002
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of mesoglycan in the treatment of venous diseases of surgical importance].
    Cianfanelli G; Borreani B; Zepponi E; Brizio L; Colotto P; Toniutti F
    Minerva Med; 1986 Oct; 77(41):1943-4. PubMed ID: 2946991
    [No Abstract]   [Full Text] [Related]  

  • 19. [A double-blind clinical trial of a topical preparation with a base of biochemical precursors of glucosaminoglycan (GAG) in patients suffering from Raynaud's disease].
    Signorini GP
    Boll Chim Farm; 1986 Oct; 125(10):103S-110S. PubMed ID: 3551995
    [No Abstract]   [Full Text] [Related]  

  • 20. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.